Skip to main content

Table 3 Number/percentage of the patients with different number of CTCs count at baseline, 3 months, and 12 months after treatment

From: Circulating tumor cells in patients undergoing androgen deprivation therapy with versus without cryosurgery for metastatic prostate cancer: a retrospective analysis

 

ADT alone, n = 23

ADT + cryosurgery, n = 20

Z value

P value

Baseline, n (%)

 < 2

0 (0%)

0 (0%)

0.789

0.430

 2‑5

11 (47.8%)

12 (60%)

 ≥5

12 (52.2%)

8 (40%)

3 months, n (%)

 < 2

4 (17.4%)

8 (40%)

2.170

0.030

 2‑5

9 (39.1%)

9 (45%)

 ≥ 5

10 (43.5%)

3 (15%)

12 months, n (%)

 < 2

9 (39.1%)

14 (70%)

2.481

0.013

 2‑5

7 (30.4%)

6 (30%)

 ≥ 5

7 (30.4%)

0 (0%)

  1. ADT androgen deprivation therapy